Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MOH✓SelectedUSD · MOHGSK vs MOH performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs MOH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
MOH return
-33.4%
Excess return
+74.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMOHExcessAlpha
1D-0.1%-2.4%+2.3%+0.1%
7D-5.3%-5.3%0.0%-4.9%
30D-3.7%-7.7%+4.0%-3.0%
3M-7.3%+0.7%-8.0%-7.4%
6M-4.2%+8.9%-13.1%-5.5%
YTD+0.9%+14.3%-13.5%-2.1%
1Y+7.3%+47.5%-40.2%+0.5%
3Y+52.7%-44.3%+97.1%+62.6%
All+41.1%-33.4%+74.5%+43.2%

Cumulative growth

Daily Returns

Daily percentage return beside MOH.

Daily Out/Under-Performance

Portfolio return minus MOH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MOH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MOH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling